Lupin launches Tolvaptan Tablets in the US with 180-day exclusivity
Tolvaptan Tablets are indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
Tolvaptan Tablets are indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
Scores highest PAT of Rs. 118 crore in FY25
Glatiramer Acetate is the generic version of Copaxone 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
This marks yet another milestone in our series of successful audits over the past year
Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic exclusivity
IGI recently completed the dose-escalation portion of its Phase 1 clinical study in patients with heavily pretreated multiple myeloma
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA
Bayer expects 2025 to be the most difficult year of its turnaround
Subscribe To Our Newsletter & Stay Updated